Displaying 13 - 24 of 24
Metabolism, Alcohol & Toxicity
3

Siemens: Non-Invasive Assessment of Liver Fibrosis in Chronic Liver Diseases - ILC 2021

View
Metabolism, Alcohol & Toxicity
3

Siemens: Non-Invasive Assessment of Liver Fibrosis in Chronic Liver Diseases - ILC 2021

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
6

Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019

View
Cirrhosis & Complications
6

Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019

View
Cirrhosis & Complications
6

Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019

View
Cirrhosis & Complications
6

Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019

View
Cirrhosis & Complications
6

Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019

View
Cirrhosis & Complications
6

Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019

View
Displaying 13 - 24 of 24